Frontlight ResearchEarly access
Trial site
Sarah Cannon and HCA Research Institute
- 4running trials
- 4closed trials
The trials here
What the 8 trials at this site are about, from their registry records.
- Conditions
- Lung cancer4 trials
- Bladder cancer2 trials
- Head and neck cancer2 trials
- Childhood cancers1 trial
- Colorectal cancer1 trial
- Gastric and oesophageal cancer1 trial
- Melanoma1 trial
- Ovarian cancer1 trial
- Pancreatic cancer1 trial
- Sarcoma1 trial
- Thyroid cancer1 trial
- Triple-negative breast cancer1 trial
- Phase
- Phase 15 trials
- Phase 1/21 trial
- Phase 21 trial
- Phase 31 trial
- Status
- Completed3 trials
- Active, not recruiting2 trials
- Recruiting2 trials
- Terminated1 trial
- Lead sponsor
- Aadi Bioscience, Inc.1 trial
- BicycleTx Limited1 trial
- C4 Therapeutics, Inc.1 trial
- Daiichi Sankyo1 trial
- Eli Lilly and Company1 trial
- and 3 more
Running trials
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Study BT5528-100 in Patients With Advanced Solid Tumors Associated With EphA2 Expression
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Bladder cancer1 recruiting
- Head and neck cancer1 recruiting
- Lung cancer1 recruiting
Closed trials
Completed
Completed
Completed
Terminated
Tazemetostat in Combination With Doxorubicin as Frontline Therapy for Advanced Epithelioid Sarcoma
Site data: ClinicalTrials.govUpdated 18 Nov 2026